Patent References 3759890 Carrier-bound protein prepared by reacting the protein with an acylating or alkylating compound having a carrier-bonding group and reacting the product with a carrier Reactive derivatives of HS-group-containing polymers Chemically modified endotoxin immunizing agent Peptide macromolecular complexes Immunogenic polysaccharide-protein conjugates Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them Coupled H. influenzae type B vaccine Patent #: 4459286 InventorsAssigneeApplicationNo. 06/719678 filed on 04/04/1985US Classes:424/197.11, Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium424/256.1, Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.)424/831, INVOLVING CAPSULAR POLYSACCHARIDE OF BACTERIUM (E.G., POLYRIBOSYL RIBITOL PHOSPHATE (PRP), ETC.)435/188, Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate530/395, Glycoprotein, e.g., mucins proteoglycans, etc.530/402, Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.530/403, Protein is identified as an antigen, e.g., immunogenic carriers, etc.530/404, Sulfur containing reactant530/405, Nitrogen containing reactant530/406, Oxygen containing reactant536/123, Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.)536/123.1, Polysaccharides536/34, Phosphorus containing acid536/55.1PolysaccharidesExaminersPrimary: Kight, JohnAssistant: Draper, Garnette D. Attorney, Agent or FirmInternational ClassesA61K 39/385 (20060101)A61K 39/39 (20060101) A61K 47/48 (20060101) C07K 17/06 (20060101) C07K 17/10 (20060101) C07K 17/00 (20060101) G01N 33/531 (20060101) G01N 33/569 (20060101) AbstractCovalently modified bacterial polysaccharides and proteins; covalent conjugates of such polysaccharides linked by a bigeneric spacer, which permits proof of covalency and facilitates purification of conjugated materials, with immunogenic bacterial membrane or other proteins, which conjugates are useful components of bacterial vaccines; and methods of preparing such polysaccharides, proteins and conjugates and of confirming the covalency of the linkage between polysaccharides and proteins.Other References
|
| ||||||||||||||